AACR Announces Fellows of the AACR Academy Class of 2026

Newly Elected Members of the 2026 Class of Fellows of the AACR Academy

• Cory Abate-Shen, PhD: Full Professor, Department of Medicine; Professor of Molecular Pharmacology and Therapeutics, Urology, and Systems Biology, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York
• Alberto Bardelli, PhD: Full Professor, Department of Oncology, University of Turin; Scientific Director, IFOM ETS – The AIRC Institute of Molecular Oncology, Milan, Italy
• Benjamin F. Cravatt, PhD: Gilula Chair of Chemical Biology; Professor, Department of Chemistry, Scripps Research, La Jolla, California
• Christina Curtis, PhD, MSc: RZ Cao Professor of Medicine, Genetics, and Biomedical Data Science; Senior Vice Chair of Research, Department of Medicine, Stanford School of Medicine; Director, Artificial Intelligence and Cancer Genomics, Stanford Cancer Institute, Stanford, California; Chan Zuckerberg Biohub Investigator
• Douglas T. Fearon, MD: Professor; Cancer Center Member, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
• Giulio F. Draetta, MD, PhD: Chief Strategy Officer, Orionis Biosciences, Waltham, Massachusetts
• Rebecca C. Fitzgerald, MD: Cantab, Professor of Cancer Prevention; Director, Early Cancer Institute; Director, Early Detection Institute; Head, Department of Oncology, University of Cambridge; Honorary Consultant in Gastroenterology, Cambridge University Hospitals NHS Foundation Trust; Research Lead, Cambridge Cancer Research Hospital, Cambridge, United Kingdom
• Sir Stephen P. Jackson, PhD: Senior Group Leader, Cancer Research UK Cambridge Institute; Frederick James Quick Professor of Biology, University of Cambridge, Cambridge, United Kingdom
• Lev L. Lanier, PhD: J. Michael Bishop, MD, Distinguished Professor Emeritus of Microbiology and Immunology, University of California, San Francisco, San Francisco, California
• Anthony G. Letai, MD, PhD: Director, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
• Ross L. Levine, MD: Chief Scientific Officer, Memorial Sloan Kettering Cancer Center, New York, New York
• Juanita L. Merchant, MD, PhD: Professor of Medicine; Chief, Division of Gastroenterology and Hepatology, University of Arizona College of Medicine; Research Member, Cancer Biology Program; Associate Director for Basic Sciences, University of Arizona Cancer Center, Tucson, Arizona
• William G. Nelson, MD, PhD, DSc: Director, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Marion I. Knott Director and Professor of Oncology, Johns Hopkins University, Baltimore, Maryland
• Garry P. Nolan, PhD: Rachford and Carlota A. Harris Professor, Department of Pathology, Stanford School of Medicine, Stanford, California
• Kenneth Offit, MD, MPH: Chief, Clinical Genetics Service; Robert and Kate Niehaus Chair in Inherited Cancer Genomics; Vice Chair of Academic Affairs, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
• Pamela S. Ohashi, PhD: Senior Scientist, UHN’s Princess Margaret Cancer Centre; Research Director, Tumor Immunology Program, Professor, Department of Immunology, University of Toronto, Toronto, Ontario, Canada
• Charles W. M. Roberts, MD, PhD: Executive Vice President and Director, St. Jude Comprehensive Cancer Center; Member, Department of Oncology; Lillian R. Cannon Comprehensive Cancer Center Director Endowed Chair, St. Jude Children’s Research Hospital, Memphis, Tennessee
• Anil K. Rustgi, MD: Herbert and Florence Irving Director, Herbert Irving Comprehensive Cancer Center; Herbert and Florence Irving Professor of Medicine, Associate Dean of Oncology, Columbia University Vagelos College of Physicians and Surgeons; Chief of the Cancer Service, NewYork-Presbyterian/Columbia University Irving Medical Center, New York, New York
• Alice T. Shaw, MD, PhD: Chair, Department of Medical Oncology; Chief of Strategic Partnerships, Dana-Farber Cancer Institute; Professor of Medicine, Harvard Medical School, Boston, Massachusetts